New York State Common Retirement Fund Vir Biotechnology, Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 24,606 shares of VIR stock, worth $182,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,606
Previous 34,006 27.64%
Holding current value
$182,084
Previous $303,000 39.27%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$7.26 - $10.7 $68,244 - $100,580
-9,400 Reduced 27.64%
24,606 $184,000
Q2 2024

Jul 31, 2024
BUY
$7.63 - $12.66 $5,386 - $8,937
706 Added 2.12%
34,006 $303,000
Q1 2024

May 07, 2024
SELL
$8.6 - $11.9 $6,389 - $8,841
-743 Reduced 2.18%
33,300 $337,000
Q4 2023

Feb 01, 2024
SELL
$7.76 - $10.29 $2,630 - $3,488
-339 Reduced 0.99%
34,043 $342,000
Q3 2023

Nov 07, 2023
SELL
$9.14 - $24.62 $97,048 - $261,415
-10,618 Reduced 23.6%
34,382 $322,000
Q2 2023

Aug 07, 2023
BUY
$23.2 - $27.29 $159,268 - $187,345
6,865 Added 18.0%
45,000 $1.1 Million
Q1 2023

May 02, 2023
SELL
$22.26 - $30.85 $858,902 - $1.19 Million
-38,585 Reduced 50.29%
38,135 $887,000
Q4 2022

Jan 30, 2023
BUY
$19.96 - $28.22 $35,508 - $50,203
1,779 Added 2.37%
76,720 $1.94 Million
Q3 2022

Nov 08, 2022
SELL
$18.26 - $31.1 $84,982 - $144,739
-4,654 Reduced 5.85%
74,941 $1.45 Million
Q2 2022

Aug 04, 2022
BUY
$19.08 - $26.7 $692,184 - $968,622
36,278 Added 83.75%
79,595 $2.03 Million
Q1 2022

May 05, 2022
BUY
$21.19 - $40.01 $572 - $1,080
27 Added 0.06%
43,317 $1.11 Million
Q4 2021

Feb 02, 2022
SELL
$30.97 - $54.03 $4,088 - $7,131
-132 Reduced 0.3%
43,290 $1.81 Million
Q3 2021

Nov 02, 2021
SELL
$34.9 - $54.54 $297,906 - $465,553
-8,536 Reduced 16.43%
43,422 $1.89 Million
Q2 2021

Aug 02, 2021
BUY
$38.75 - $51.0 $133,997 - $176,358
3,458 Added 7.13%
51,958 $2.46 Million
Q3 2020

Nov 05, 2020
BUY
$28.28 - $53.6 $169,680 - $321,600
6,000 Added 14.12%
48,500 $1.67 Million
Q2 2020

Aug 07, 2020
BUY
$27.89 - $47.86 $956,627 - $1.64 Million
34,300 Added 418.29%
42,500 $1.74 Million
Q4 2019

Feb 05, 2020
BUY
$11.83 - $15.85 $97,006 - $129,970
8,200 New
8,200 $103,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email